Anika Therapeutics Stock Price History

ANIK Stock  USD 17.72  0.52  3.02%   
Below is the normalized historical share price chart for Anika Therapeutics extending back to May 03, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Anika Therapeutics stands at 17.72, as last reported on the 29th of November, with the highest price reaching 17.98 and the lowest price hitting 17.65 during the day.
IPO Date
29th of April 1993
200 Day MA
24.8421
50 Day MA
21.9244
Beta
0.857
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Anika Stock, it is important to understand the factors that can impact its price. Anika Therapeutics secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Anika Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anika Therapeutics' Mean Deviation of 1.77, standard deviation of 4.16, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
  
Capital Stock is expected to rise to about 158.6 K this year, although the value of Total Stockholder Equity will most likely fall to about 120.9 M. . At this time, Anika Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 1.73 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (176.45). Anika Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1057

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsANIK

Estimated Market Risk

 4.23
  actual daily
37
63% of assets are more volatile

Expected Return

 -0.45
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Anika Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anika Therapeutics by adding Anika Therapeutics to a well-diversified portfolio.
Price Book
1.4429
Enterprise Value Ebitda
(72.65)
Price Sales
1.5808
Shares Float
10.6 M
Wall Street Target Price
26.5

Anika Therapeutics Stock Price History Chart

There are several ways to analyze Anika Stock price data. The simplest method is using a basic Anika candlestick price chart, which shows Anika Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 9, 202425.53
Lowest PriceNovember 5, 202416.3

Anika Therapeutics November 29, 2024 Stock Price Synopsis

Various analyses of Anika Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Anika Stock. It can be used to describe the percentage change in the price of Anika Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Anika Stock.
Anika Therapeutics Price Daily Balance Of Power 1.58 
Anika Therapeutics Price Rate Of Daily Change 1.03 
Anika Therapeutics Price Action Indicator 0.16 

Anika Therapeutics November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Anika Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Anika Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Anika Stock and then apply it to test your longer-term investment strategies against Anika.

Anika Stock Price History Data

The price series of Anika Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 9.55 with a coefficient of variation of 16.12. The prices are distributed with arithmetic mean of 22.55. The median price for the last 90 days is 24.63.
OpenHighLowCloseVolume
11/29/2024
 17.73  17.98  17.65  17.72 
11/27/2024 17.73  17.98  17.65  17.72  99,574 
11/26/2024 17.20  17.77  17.10  17.72  108,870 
11/25/2024 17.09  17.63  17.09  17.20  146,974 
11/22/2024 17.54  17.62  16.95  16.97  89,496 
11/21/2024 17.21  17.59  17.03  17.43  83,891 
11/20/2024 17.06  17.22  16.82  17.18  168,341 
11/19/2024 17.02  17.16  16.70  17.04  96,672 
11/18/2024 17.19  17.35  16.80  17.04  137,628 
11/15/2024 17.14  17.26  16.41  17.25  188,262 
11/14/2024 17.19  17.19  16.50  17.00  145,381 
11/13/2024 17.00  17.07  16.70  17.04  128,613 
11/12/2024 17.08  17.16  16.55  16.88  169,812 
11/11/2024 17.28  17.85  16.96  17.07  106,751 
11/08/2024 17.10  17.50  16.75  17.26  128,753 
11/07/2024 17.13  17.34  16.93  17.23  129,142 
11/06/2024 16.50  17.51  16.31  17.27  252,374 
11/05/2024 17.17  17.24  16.15  16.30  222,691 
11/04/2024 16.43  17.56  16.10  17.07  221,832 
11/01/2024 17.18  17.73  16.30  16.53  285,961 
10/31/2024 24.12  24.12  16.00  17.11  417,694 
10/30/2024 24.52  24.85  24.52  24.68  52,314 
10/29/2024 24.61  24.83  24.43  24.52  53,915 
10/28/2024 24.51  25.00  24.43  24.66  67,396 
10/25/2024 24.58  24.79  24.32  24.32  31,893 
10/24/2024 24.52  24.73  24.41  24.51  44,293 
10/23/2024 24.59  24.59  24.24  24.54  71,572 
10/22/2024 24.48  24.92  24.44  24.70  49,916 
10/21/2024 24.95  25.24  24.39  24.44  32,699 
10/18/2024 25.29  25.44  24.90  25.06  29,626 
10/17/2024 25.29  25.39  24.93  25.15  28,212 
10/16/2024 25.32  25.45  25.07  25.21  32,438 
10/15/2024 25.34  25.63  25.11  25.15  41,890 
10/14/2024 25.49  25.50  25.21  25.34  24,188 
10/11/2024 25.27  25.65  25.27  25.38  28,039 
10/10/2024 25.34  25.34  24.75  25.25  46,661 
10/09/2024 24.58  25.59  24.26  25.53  60,443 
10/08/2024 24.47  24.95  24.47  24.64  45,803 
10/07/2024 25.00  25.21  24.33  24.35  52,007 
10/04/2024 25.43  25.48  24.99  24.99  26,046 
10/03/2024 24.99  25.51  24.97  25.28  97,861 
10/02/2024 24.40  25.19  24.31  25.02  118,335 
10/01/2024 24.64  24.64  24.16  24.27  41,642 
09/30/2024 24.56  24.98  24.56  24.70  22,553 
09/27/2024 24.74  24.92  24.42  24.56  53,222 
09/26/2024 24.96  25.04  24.62  24.63  23,042 
09/25/2024 24.72  24.85  24.36  24.69  72,893 
09/24/2024 25.02  25.02  24.58  24.71  54,455 
09/23/2024 25.48  25.54  24.87  25.02  37,698 
09/20/2024 25.20  25.54  24.82  25.50  399,023 
09/19/2024 25.83  25.83  25.26  25.36  39,395 
09/18/2024 25.08  26.00  25.01  25.47  43,594 
09/17/2024 25.07  25.89  24.83  25.20  50,377 
09/16/2024 24.77  25.60  24.59  24.86  31,116 
09/13/2024 24.56  25.03  24.47  24.64  36,655 
09/12/2024 24.31  24.67  24.20  24.42  28,353 
09/11/2024 24.43  24.51  24.15  24.25  25,759 
09/10/2024 24.29  24.67  24.27  24.59  31,151 
09/09/2024 24.43  24.77  24.15  24.27  40,825 
09/06/2024 25.30  25.30  24.55  24.56  34,439 
09/05/2024 25.24  25.41  24.74  25.31  44,693 

About Anika Therapeutics Stock history

Anika Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anika is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anika Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anika Therapeutics stock prices may prove useful in developing a viable investing in Anika Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.7 M12.7 M
Net Loss-17.1 M-16.2 M

Anika Therapeutics Quarterly Net Working Capital

110.61 Million

Anika Therapeutics Stock Technical Analysis

Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Anika Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Anika Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Anika Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Anika Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Anika Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anika to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Anika Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Anika Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Anika Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Anika Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.51)
Earnings Share
(6.64)
Revenue Per Share
11.139
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.04)
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.